Multimedia
View More
Hear these expert faculty as they discuss questions such as, “Do outcomes from DAPA-HF and EMPEROR-Reduced suggest a class effect of SGLT2 inhibitors?” “Is it safe to start ARNI in the hospital, and does it influence post discharge outcomes?” “What is the likely place of emerging therapies like vericiguat and omecamtiv mecarbil in HFrEF?”
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.